Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.

The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors.

Shaw BE, Russell NH, Devereux S, Das-Gupta E, Mackinnon S, Madrigal JA, Pagliuca A, Mufti GJ, Byrne JL.

Haematologica. 2005 Nov;90(11):1562-9.

2.

Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.

Bornhäuser M, Theuser C, Soucek S, Hölig K, Klingebiel T, Blau W, Fauser A, Runde V, Schwinger W, Rutt C, Ehninger G.

Haematologica. 2000 Aug;85(8):839-47.

3.

Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients.

Bornhäuser M, Thiede C, Platzbecker U, Jenke A, Helwig A, Plettig R, Freiberg-Richter J, Röllig C, Geissler G, Lutterbeck K, Oelschlagel U, Ehninger G.

Clin Cancer Res. 2001 Aug;7(8):2254-62.

4.

Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.

Chewning JH, Castro-Malaspina H, Jakubowski A, Kernan NA, Papadopoulos EB, Small TN, Heller G, Hsu KC, Perales MA, van den Brink MR, Young JW, Prockop SE, Collins NH, O'Reilly RJ, Boulad F.

Biol Blood Marrow Transplant. 2007 Nov;13(11):1313-23. Epub 2007 Sep 7.

5.

Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.

Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.

Klin Padiatr. 2005 May-Jun;217(3):135-41.

PMID:
15858704
6.

Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease.

Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK, McGlave PB, Sender L, Cairo MS.

Blood. 1996 Aug 1;88(3):795-802.

7.

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM.

N Engl J Med. 2004 Nov 25;351(22):2265-75.

8.

Stable engraftment after a conditioning regimen with fludarabine and melphalan for bone marrow transplantation from an unrelated donor.

Inamoto Y, Oba T, Miyamura K, Terakura S, Tsujimura A, Kuwatsuka Y, Tokunaga M, Kasai M, Murata M, Naoe T, Kodera Y.

Int J Hematol. 2006 May;83(4):356-62.

PMID:
16757439
9.

Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.

Lee KH, Lee JH, Lee JH, Kim DY, Kim SH, Shin HJ, Lee YS, Kang YA, Seol M, Ryu SG.

Biol Blood Marrow Transplant. 2009 Jan;15(1):61-72. doi: 10.1016/j.bbmt.2008.10.025.

10.

Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources.

Souillet G, Guffon N, Maire I, Pujol M, Taylor P, Sevin F, Bleyzac N, Mulier C, Durin A, Kebaili K, Galambrun C, Bertrand Y, Froissart R, Dorche C, Gebuhrer L, Garin C, Berard J, Guibaud P.

Bone Marrow Transplant. 2003 Jun;31(12):1105-17.

PMID:
12796790
11.

Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program.

Davies SM, Kollman C, Anasetti C, Antin JH, Gajewski J, Casper JT, Nademanee A, Noreen H, King R, Confer D, Kernan NA.

Blood. 2000 Dec 15;96(13):4096-102.

12.

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.

Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, Remberger M, Michel G, Arcese W, Dallorso S, Tiedemann K, Busca A, Chan KW, Kato S, Ortega J, Vowels M, Zander A, Souillet G, Oakill A, Woolfrey A, Pay AL, Green A, Garnier F, Ionescu I, Wernet P, Sirchia G, Rubinstein P, Chevret S, Gluckman E.

Blood. 2001 May 15;97(10):2962-71.

13.

Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium.

Yu LC, Wall DA, Sandler E, Chan KW, Grayson G, Kletzel M.

Pediatr Hematol Oncol. 2001 Jun;18(4):235-45.

PMID:
11400647
14.

Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.

Teshima T, Matsuo K, Matsue K, Kawano F, Taniguchi S, Hara M, Hatanaka K, Tanimoto M, Harada M, Nakao S, Abe Y, Wake A, Eto T, Takemoto Y, Imamura M, Takahashi S, Ishida Y, Kanda Y, Kasai M, Takaue Y.

Br J Haematol. 2005 Aug;130(4):575-87.

PMID:
16098073
15.

Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.

Schönberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kögler G, Enzmann J, Wernet P, Göbel U, Dilloo D.

Klin Padiatr. 2004 Nov-Dec;216(6):356-63.

PMID:
15565551
16.

[Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].

Faber E, Koza V, Vítek A, Mayer J, Sedlácek P, Zák P, Zapletalová J, Benesová K, Krejcová H, Steinerová K, Maresová I, Cetkovský P.

Vnitr Lek. 2006 Dec;52(12):1172-80. Czech.

PMID:
17299910
17.

Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.

Ayuk F, Diyachenko G, Zabelina T, Panse J, Wolschke C, Eiermann T, Binder T, Fehse B, Erttmann R, Kabisch H, Bacher U, Kröger N, Zander AR.

Exp Hematol. 2008 Aug;36(8):1047-54. doi: 10.1016/j.exphem.2008.03.011. Epub 2008 May 5.

PMID:
18456390
18.

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor.

Sayer HG, Kröger M, Beyer J, Kiehl M, Klein SA, Schaefer-Eckart K, Schwerdtfeger R, Siegert W, Runde V, Theuser C, Martin H, Schetelig J, Beelen DW, Fauser A, Kienast J, Höffken K, Ehninger G, Bornhäuser M; Cooperative German Transplant Study Group.

Bone Marrow Transplant. 2003 Jun;31(12):1089-95.

PMID:
12796788
19.

Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.

Maury S, Balère-Appert ML, Chir Z, Boiron JM, Galambrun C, Yakouben K, Bordigoni P, Marie-Cardine A, Milpied N, Kanold J, Maillard N, Socié G; French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Haematologica. 2007 May;92(5):589-96.

20.

Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.

Davies SM, DeFor TE, McGlave PB, Miller JS, Verfaillie CM, Wagner JE, Weisdorf DJ.

Am J Med. 2001 Apr 1;110(5):339-46.

PMID:
11286947
Items per page

Supplemental Content

Write to the Help Desk